Implant Sciences [IMSC] 4Q13 4Q12 FY13 FY12 Sales $2.4M $600,000 $12M $3.4M Net Inc. ($5.5M, 0.10) ($4.4M, 0.12) ($27.4M, 0.56)($14.6M, 0.43) The net loss in the fourth quarter widened on an increase of $1.6 million of stock-based compensation expense, higher operating expenses and increased interest expense on higher borrowings under the company’s credit facility. Expenses were also up on the addition of more sales personnel and related travel as well as a 51% percent increase in research and development to…
Recommended
Trending
Congress Updates
Counter-Drone Needs Will Be Addressed In Next NDAA Based On Iran War Lessons, Banks Says
A Republican senator on Armed Services Committee on Thursday said that defending against Iranian drones has been challenge for U.S. warfighters and will be an area of focus in the […]
Pentagon ‘Working Options’ On Iran Supplemental, May Seek Funds For New Capabilities
The Pentagon is “working options” for a potential supplemental spending request to fund the operation against Iran and replenish munitions used in the strike campaign, with a senior official noting […]
Wicker Backs “Crash Program” To Supply Ukraine With Low-Cost Weapons
Senate Armed Services Committee (SASC) Chairman Roger Wicker (R-Miss.) on Thursday proposed a rapid effort to supply Ukraine with low-cost weapons to aid that country in turning back Russia. “We […]
Dem Lawmakers Want To Codify Trump’s Push For More Defense Contractor Accountability
A group of four Congressional Democrats want to codify President Donald Trump’s push to hold defense firms accountable for prioritizing production investments over paying out stock buybacks, and are seeking […]